Target: CD3
[1]. Ogura M, et, al. Oral treatment with foralumab, a fully human anti-CD3 monoclonal antibody, prevents skin xenograft rejection in humanized mice. Clin Immunol. 2017 Oct;183:240-246.
陕西缔都医药有限责任公司
联系商家时请提及chemicalbook,有助于交易顺利完成!